跳到主要导航 跳到搜索 跳到主要内容

Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)

  • Jing Gao
  • , Bo Hou
  • , Qiwen Zhu
  • , Lei Yang
  • , Xingyu Jiang
  • , Zhifeng Zou
  • , Xutong Li
  • , Tianfeng Xu
  • , Mingyue Zheng
  • , Yi Hung Chen
  • , Zhiai Xu*
  • , Huixiong Xu*
  • , Haijun Yu*
    • *此作品的通讯作者
  • Department of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor
  • Tongji University
  • CAS - Shanghai Institute of Materia Medica
  • Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development
  • East China Normal University
  • School of Chinese Materia Medica
  • Nanjing University of Chinese Medicine
  • Wuhan University
  • Department of Ultrasound
  • Fudan University

科研成果: 期刊稿件 › 评论/辩论

5   在新选项卡中打开链接 引用 （Scopus）

摘要

The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct imagesweremissing. This has been corrected in both the PDF andHTML versions of the Article.

源语言英语
期刊论文编号4978
期刊Nature Communications
卷13
期1
DOI
出版状态已出版 - 12月 2022

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

访问文件

其它文件与链接

学术指纹

探究 'Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy (Nature Communications, (2022), 13, 1, (4318), 10.1038/s41467-022-32050-4)' 的科研主题。它们共同构成独一无二的学术指纹。
查看全学术指纹

引用此